Silexion Therapeutics Corp (SLXN)
NASDAQ: SLXN · Real-Time Price · USD
1.050
+0.060 (6.04%)
Apr 14, 2026, 4:00 PM EDT - Market closed
Silexion Therapeutics Market Cap
Silexion Therapeutics has a market cap or net worth of $3.48 million as of April 14, 2026. Its market cap has decreased by -64.95% in one year.
Market Cap
3.48M
Enterprise Value
-656.86K
1-Year Change
-64.95%
Ranking
Category
Stock Price
$1.05
Market Cap Chart
Since April 7, 2021, Silexion Therapeutics's market cap has decreased from $148.55M to $3.48M, a decrease of -97.66%. That is a compound annual growth rate of -52.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 13, 2026 | 3.30M | -45.06% |
| Dec 31, 2025 | 6.00M | 86.31% |
| Dec 31, 2024 | 3.22M | -92.33% |
| Dec 21, 2023 | 41.99M | -71.93% |
| Dec 30, 2022 | 149.59M | 4.03% |
| Dec 31, 2021 | 143.80M | -3.20% |
| Apr 7, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| VivoSim Labs | 3.76M |
| Enveric Biosciences | 3.72M |
| GRI Bio | 3.47M |
| Azitra | 3.45M |
| Alzamend Neuro | 3.42M |
| GeoVax Labs | 3.36M |
| Decoy Therapeutics | 3.23M |
| Matinas BioPharma Holdings | 3.22M |